Advertisement
UK markets close in 3 hours 14 minutes

  • FTSE 100

    8,337.32
    +23.65 (+0.28%)
     

  • FTSE 250

    20,408.41
    -4.67 (-0.02%)
     

  • AIM

    777.56
    +1.14 (+0.15%)
     

  • GBP/EUR

    1.1614
    -0.0010 (-0.08%)
     

  • GBP/USD

    1.2478
    -0.0032 (-0.25%)
     

  • Bitcoin GBP

    50,025.54
    -988.73 (-1.94%)
     

  • CMC Crypto 200

    1,321.06
    +26.39 (+2.04%)
     

  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     

  • DOW

    38,884.26
    +31.99 (+0.08%)
     

  • CRUDE OIL

    77.37
    -1.01 (-1.29%)
     

  • GOLD FUTURES

    2,325.40
    +1.20 (+0.05%)
     

  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     

  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     

  • DAX

    18,485.55
    +55.50 (+0.30%)
     

  • CAC 40

    8,143.70
    +68.02 (+0.84%)
     
Money:

How to make a tax-free income

Tips for making money that won't be taxed

EU signs contract with AstraZeneca on supply of potential COVID-19 vaccine

Reuters
Updated ·1-min read
FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield

BRUSSELS (Reuters) - The European Commission said on Thursday it had signed a contract on behalf of EU states with British drugmaker AstraZeneca <AZN.L> for the supply of at least 300 million doses of its COVID-19 vaccine candidate.

The move follows an advance purchase agreement signed by Brussels with AstraZeneca earlier in August.

It is the first contract signed by the EU with a maker of potential COVID-19 vaccines. The contract envisages an option to purchase 100 million additional doses to be distributed on a population-based pro-rata basis among the 27 EU states.

(Reporting by Francesco Guarascio @fraguarascio; Editing by Hugh Lawson)